9 December 2023
Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and Secured Financing Deal from Braidwell
Advising firms
Deal team
29 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Daniel Rees Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Elizabeth Oh Lead | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Haim Zaltzman Lead | Latham & Watkins LLP | Partner | Not stated | Not stated |
| Abby Timmons | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Erik Jensen | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare | Not stated |
| Leia Gu | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Not stated |
| Mitch Bennett | Latham & Watkins LLP | Associate | data privacy | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Not stated |
| Trevor Thompson | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Arielle Singh | Latham & Watkins LLP | Counsel | IP | Not stated |
| Fiona Gillan | Latham & Watkins LLP | Associate | IP | Not stated |
| James Metz | Latham & Watkins LLP | Partner | benefits and compensation | Not stated |
| Nimra Syed | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Not stated |
| Kathryn Harrington | Latham & Watkins LLP | Associate | tax | Not stated |
| Benjamin Gelfand | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Tyler Davis | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Carry Chen | Latham & Watkins LLP | Partner | UK debt | Not stated |
| Mark Walker | Latham & Watkins LLP | Associate | UK debt | Not stated |
| Phillip Stoup | Latham & Watkins LLP | Partner | corporate | Not stated |
| Laura Ferrell | Latham & Watkins LLP | Partner | securities regulatory | Not stated |
| Joel Cavanaugh | Latham & Watkins LLP | Counsel | securities regulatory | Not stated |
| Emily Yu | Latham & Watkins LLP | Counsel | security | Not stated |
| Eric Rice | Latham & Watkins LLP | Partner | converts | Not stated |
| Ryan Gold | Latham & Watkins LLP | Associate | converts | Not stated |
| Andrew Bentz | Latham & Watkins LLP | Associate | converts | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | healthcare / regulatory | Not stated |
Stated terms
- Stated value
- USD 40m (US$40 million)
- What the figure measures
- Total transaction value
- Client
- Nevro Corp.Buy-side
- Counterparties
- Vyrsa Technologies (Sell-side)
Braidwell LP (Lenders)